20080763 Panitumumab vs Cetuximab in Colorectal Cancer

• Research type

  Research Study

• Full title

  A Randomized, Multicenter, Open-label, Phase 3 Study to Compare the Efficacy and Safety of Panitumumab and Cetuximab in Subjects with Previously Treated, Wild-type KRAS, Metastatic Colorectal Cancer.

• IRAS ID

  30640

• Eudract number

  2009-010715-32

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• Research summary

  N/A

• REC name

  East Midlands - Leicester South Research Ethics Committee

• REC reference

  09/H0402/92

• Date of REC Opinion

  27 Nov 2009

• REC opinion

  Further Information Favourable Opinion